The ALS Therapy Development Institute (ALS TDI) is
offering the opportunity to participate as an official entrant in
the 2026 Schneider Electric Marathon de Paris
Marathon to be held Sunday, April 12, 2026. Before completing the application form
below, it is important to note that there is a $3,500 fundraising minimum required of the successful applicant. Those funds support ALS TDI's mission to find effective
treatments and cures for Amyotrophic Lateral Sclerosis (ALS).
ABOUT THE ALS THERAPY DEVELOPMENT INSTITUTE (ALS TDI)
ALS TDI is the world's foremost drug discovery center focused solely on Amyotrophic Lateral Sclerosis (ALS). As a nonprofit biotech, its Watertown, MA-based science team actively discovers and develops treatments for ALS. Led by people with ALS and drug development experts, ALS TDI understands the urgent need to slow and stop this disease.
Visit www.als.net for more information.
ABOUT ALS
Amyotrophic lateral sclerosis (ALS), also known as Motor Neuron Disease (MND), Lou Gehrig's Disease, and Charcot's disease, is a progressive neurodegenerative disease that attacks motor neurons in the brain and spinal cord. This results in the wasting away of muscle, loss of movement and eventual paralysis. There are an estimated 30,000 people living with ALS in the United States at any given time. Every 90 minutes, someone is diagnosed with ALS. About 90% of all ALS cases are sporadic with no known history of the disease in a family. The remaining 10% of cases are known as familial ALS.
FUNDRAISING MINIMUM
The minimum fundraising requirement is $3,5001
and must be reached by Sunday, April 12, 2026.
APPLICATION DEADLINE
Please complete and submit this application by Friday, November 7, 2025,
to be considered. Successful applicants will be chosen by internal selection committee, and notified no later than
Friday, November 21, 2025.
1
While $3,500 is the minimum fundraising requirement, it
is our mission to develop treatments for ALS as quickly as possible, and thus we will take note of those
applicants with a strategy to raise funds beyond $3,500.